Ignite Creation Date:
2025-12-24 @ 5:53 PM
Ignite Modification Date:
2025-12-27 @ 4:19 AM
Study NCT ID:
NCT02188368
Status:
TERMINATED
Last Update Posted:
2023-11-03
First Post:
2014-07-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pomalidomide for Lenalidomide for Relapsed or Refractory Multiple Myeloma Patients
Sponsor:
Oncotherapeutics
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
PO-CL-MM-PI-003854
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |